LEADER 01673nam  2200457   450 
001 9910707236803321
005 20160622111023.0
035   $a(CKB)5470000002463142
035   $a(OCoLC)952030802
035   $a(OCoLC)995470000002463142
035   $a(EXLCZ)995470000002463142
100   $a20160622d2009      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aMedicare drug integrity contractors' identification of potential Part D fraud and abuse
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d2009.
215   $a1 online resource (v, 23 pages) $cillustrations
300   $aTitle from title screen (viewed June 21, 2016).
300   $a"October 2009."
300   $a"OEI-03-08-00420."
320   $aIncludes bibliographical references.
517 1 $aMEDICs' identification of potential Part D fraud and abuse
606   $aMedicare fraud
606   $aGovernment contractors$zUnited States$xAuditing
606   $aDrug factories$zUnited States$xAuditing
606   $aPharmaceutical industry$zUnited States$xAuditing
606   $aPharmaceutical policy$zUnited States
615  0$aMedicare fraud.
615  0$aGovernment contractors$xAuditing.
615  0$aDrug factories$xAuditing.
615  0$aPharmaceutical industry$xAuditing.
615  0$aPharmaceutical policy
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910707236803321
996   $aMedicare drug integrity contractors' identification of potential Part D fraud and abuse$93310683
997   $aUNINA